Dr. Inder's research focuses on understanding the nature and timing of brain injury and altered brain development in the high risk newborn infant. She is a dual boarded neonatologist and child neurologist who applies advanced magnetic resonance imaging and electroencephalographic tools to assist in defining brain injury. She co-ordinates randomized controlled intervention studies including pomegranate in mothers with growth restricted infants, caffeine and parenteral intervention programs in prematurely born infants and hypothermia in term born encephalopathic infants to improve neurodevelopmental outcomes. Her team is multidisciplinary with radiology, neurology, neurosurgery, obstetrics, pscyhology and psychiatry.